SAGILITY LTD Quarterly Results Analysis-Q2FY2027

SAGILITY Financial performance and key operating metrics (Consolidated) : Operating Revenue for Q2FY27 is Rs. 2,032 Crs., 22.53% growth YoY, Total Income is Rs. 2,045 Crs., 19.12% growth YoY, EBITDA is Rs. 512 Crs., 23.41% growth YoY, EBITDA Margin is 25.21% improved by 18 Basis points YoY, PBT Rs. 374 Crs. 14.51% growth YoY, PAT Rs. 284 Crs. 13.31% growth YoY. On QoQ basis Op. Revenue is up by 3.49%, Total Income is up by 3.39%, EBITDA is up by 16.93%, PBT is up by 30.17% PAT is up by 31.09%. Deal ACV $40.2m, +18.2% YoY, across “31 existing clients and one new client.” Cash: OCF INR 3,182m, FCF INR 2,760m on track to repay outstanding debt fully during FY27, supporting lower finance cost and flexibility. Sagility improves efficiency on both sides; having both sides can help reduce payer-provider friction around denials and payment delays Clear shift in partner selection criteria towards domain + practical AI + outcome ownership: clients want partners “willing to take accountability for outcomes.” Sales cycles for large transformations are likely longer/more proof-driven, but Sagility believes its positioning (healthcare domain depth + AI + managed services + outcomes orientation) is increasingly aligned with how buyers are selecting vendors.